A Prospective Cohort Study Comparing Disparity in Surgical Procedure (Wide Local Excision Only vs Any Other Surgery Procedures) Among the Elderly Breast Cancer Patients
Launched by PEKING UNION MEDICAL COLLEGE HOSPITAL · Jun 8, 2020
Trial Information
Current as of November 05, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is investigating the differences between two types of surgical procedures for elderly women with breast cancer: wide local excision (WLE), which removes the tumor and a small margin of surrounding tissue, and other surgical options. The aim is to understand how these different surgeries affect survival outcomes for older patients, especially since many elderly women are not included in traditional studies, making it hard to know the best treatment for them. Researchers want to see if those who undergo WLE fare differently compared to those who receive other surgical treatments, helping to ensure that older patients receive the most appropriate care.
To participate in this study, women must have a clinical diagnosis of breast cancer and have received surgical treatment at the participating hospital. They also need to agree to long-term follow-up and have no evidence of cancer spread to other parts of the body. If you or a loved one is considering joining this trial, you can expect to be monitored closely to see how the surgery impacts health outcomes over time. This study is important because it aims to provide clearer guidance for treating breast cancer in elderly patients, ensuring they receive the right level of care tailored to their needs.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Clinical diagnosis of breast cancer
- • Received surgical treatment in this institution
- • Specific surgical method data available
- • Demographic and pathological data available
- • No clear evidence of distant metastasis
- • Agree to participate in the trial and receive long-term follow-up
- Exclusion Criteria:
- • Being intolerant of surgical treatment
- • Distant metastases have been merged
- • Patients who had simultaneous bilateral breast cancer
- • Follow-up interval being less than 12 months except reaching endpoints of observation
About Peking Union Medical College Hospital
Peking Union Medical College Hospital (PUMCH) is a prestigious medical institution and a leading research facility located in Beijing, China. Affiliated with the Chinese Academy of Medical Sciences, PUMCH is renowned for its commitment to advancing healthcare through innovative clinical research and high-quality patient care. The hospital plays a pivotal role in the development and execution of clinical trials across various medical disciplines, focusing on improving treatment outcomes and enhancing medical knowledge. With a multidisciplinary team of experts and state-of-the-art facilities, PUMCH is dedicated to contributing to global health advancements and fostering collaborations in the medical research community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Beijing, Beijing, China
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials